A Study of Q-switched Nd:YAG Laser versus Itraconazole in Management of Onychomycosis

Abstract Context: Onychomycosis (OM) accounts for 20%–40% of all nail disorders. Slow growth of nails, resistance to antifungal drugs, their side effects, and drug interactions limit treatment options. Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser is approved for nail clearance of OM, however conflicting reports exist in literature about its efficacy. This study was conducted to compare the efficacy of Q-switched Nd:YAG laser. Aim: The aim of this study was to find the efficacy of Q-switched Nd:YAG laser (1064 nm) management of OM as monotherapy in comparison to itraconazole. Settings and Design: A randomized parallel group, outcome assessor trial was conducted over 18 months from July 1, 2015 to December 31, 2016, at skin center of a tertiary care hospital. Subjects and Methods: In the first group, patients of OM were administered 12 weekly sessions of the laser. Second group was administered itraconazole 200 mg twice a day for 1 week per month for the 3 months. Confirmed cases of OM, who had not received treatment 6 months before presentation, were selected and randomly allocated to two groups of 50 each. Onychomycosis severity index (OSI) and visual analog scale (VAS) score were used to assess nail involvement at the start of study, 3 months and 1 year after enrollment. Statistical Analysis: Clinical profile of patients was analyzed by chi-square test for qualitative variables. For comparison of quantitative variables, Student t test was performed. A 5% probability level was considered as statistically significant (P < 0.05). Results: VAS and OSI showed statistically significant improvement at 3 and 12 months in Group I, while resulting in faster clearance with laser; OSI was comparable in both groups at 12 months. Mycological cure was significantly higher in Group I. Both dermatophytes as well as non-dermatophytes responded well to laser treatment, whereas non-dermatophytes responded better to laser. Conclusions: Q-switched Nd:YAG laser is effective in inducing nail clearance in OM and is better than itraconazole in managing non-dermatophyte OM.

[1]  N. Asifa,et al.  Current mycological profile of onychomycosis in Kashmir valley: A hospital-based study , 2017, Journal of laboratory physicians.

[2]  S. Panda,et al.  The menace of dermatophytosis in India: The evidence that we need , 2017, Indian journal of dermatology, venereology and leprology.

[3]  Aditya K. Gupta,et al.  Lasers for Onychomycosis , 2017, Journal of cutaneous medicine and surgery.

[4]  M. Jünger,et al.  Treating onychomycosis with the short‐pulsed 1064‐nm‐Nd:YAG laser: results of a prospective randomized controlled trial , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  Xiuli Wang,et al.  A review of the mechanism of action of lasers and photodynamic therapy for onychomycosis , 2017, Lasers in Medical Science.

[6]  Erika Shor,et al.  Update on Antifungal Drug Resistance , 2015, Current Clinical Microbiology Reports.

[7]  B. Piraccini,et al.  Onychomycosis: A Review , 2015, Journal of fungi.

[8]  D. Yadav,et al.  The nondermatophyte molds: Emerging as leading cause of onychomycosis in south-east Rajasthan , 2015, Indian dermatology online journal.

[9]  Rishi Sharma,et al.  Onychomycosis: A clinicomycological study from western Uttar Pradesh, India , 2015 .

[10]  U. Keyal,et al.  Laser treatment for onychomycosis: a review , 2014, Mycoses.

[11]  S. Feldman,et al.  Comorbidity of Tinea Pedis and Onychomycosis and Evaluation of Risk Factors in Latino Immigrant Poultry Processing and Other Manual Laborers , 2014, Southern medical journal.

[12]  R. Gorton,et al.  Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. , 2014, The Journal of antimicrobial chemotherapy.

[13]  K. Fritz,et al.  The Effect of Q-Switched Nd:YAG 1064 nm/532 nm Laser in the Treatment of Onychomycosis In Vivo , 2013, Dermatology research and practice.

[14]  J. Simon,et al.  Antifungal efficacy of lasers against dermatophytes and yeasts in vitro , 2013, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[15]  Aditya K. Gupta,et al.  Medical devices for the treatment of onychomycosis , 2012, Dermatologic therapy.

[16]  B. Elewski,et al.  A new classification system for grading the severity of onychomycosis: Onychomycosis Severity Index. , 2011, Archives of dermatology.

[17]  A. Singal,et al.  Onychomycosis: Diagnosis and management. , 2011, Indian journal of dermatology, venereology and leprology.

[18]  R. Baran.  The nail in the elderly. , 2011, Clinics in dermatology.

[19]  Gregory M. Peterson,et al.  Toenail onychomycosis: an important global disease burden , 2010, Journal of clinical pharmacy and therapeutics.

[20]  Jasmina Kozarev,et al.  Novel Laser Therapy in Treatment of Onychomycosis , 2010 .

[21]  S. Teerthanath,et al.  Comparison of potassium hydroxide mount and mycological culture with histopathologic examination using periodic acid-Schiff staining of the nail clippings in the diagnosis of onychomycosis. , 2008, Indian journal of dermatology, venereology and leprology.

[22]  E. Vural,et al.  The effects of laser irradiation on Trichophyton rubrum growth , 2008, Lasers in Medical Science.

[23]  M. Gupta,et al.  Onychomycosis: Clinico-mycologic study of 130 patients from Himachal Pradesh, India. , 2007, Indian journal of dermatology, venereology and leprology.

[24]  R. Summerbell,et al.  The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease , 2000, Journal of the European Academy of Dermatology and Venereology : JEADV.

[25]  B. Elewski,et al.  A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. , 2000, Journal of the American Academy of Dermatology.

[26]  C. R. Daniel,et al.  Itraconazole for the treatment of onychomycosis. , 1998, International journal of dermatology.

[27]  T. Rantanen,et al.  A double‐blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe–nail onychomycosis , 1997, The British journal of dermatology.